Format

Send to

Choose Destination
Leukemia. 2019 Jun 7. doi: 10.1038/s41375-019-0504-y. [Epub ahead of print]

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Author information

1
Institute for Molecular Medicine Finland, FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
2
Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
3
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
4
Institute for Molecular Medicine Finland, FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. caroline.heckman@helsinki.fi.
PMID:
31175323
DOI:
10.1038/s41375-019-0504-y

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center